Inhibition of C3/C3aR Pathway Alleviates Visual and Optic Nerve Impairments in a Rat Model of Neuromyelitis Optica Spectrum Disorder
Authors:
- 22 April 2025
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 61 (8) , e70103
Abstract
Accumulating evidence suggests that the complement C3/C3a receptor (C3aR) pathway plays a pivotal role in the pathogenesis of neurodegenerative and autoimmune disorders, particularly neuromyelitis optica spectrum disorders (NMOSDs). Despite this, the specific pathogenic effect and mechanism of C3/C3aR pathway in NMOSD remains elusive. In this study, we demonstrated for the first time that the expression of C3aR and its upstream ligand C3 is significantly upregulated in the optic nerve of a rat model of NMOSD‐related optic neuritis (NMOSD‐ON). Our findings reveal that this upregulation leads to blood–brain barrier (BBB) disruption, demyelination and neuronal damage. Through the use of a novel C3aR inhibitor, JR14a, we demonstrate its effectiveness in reducing C3aR expression and mitigating pathological damage in the optic nerve. Furthermore, our transcriptome sequencing analysis of NMOSD optic nerve tissues reveals extensive enrichment of inflammation‐ and immune response–related pathways, with particular emphasis on the complement and coagulation cascades pathway. This study not only elucidated the crucial role of the C3‐C3aR pathway in NMOSD‐ON pathogenesis but also provided a new promising therapeutic target for NMOSD through C3aR pathway inhibition.Keywords
Funding Information
- National Natural Science Foundation of China (81870656)
- Natural Science Foundation of Guangdong Province (2017A030313610)
This publication has 62 references indexed in Scilit:
- Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative responseExperimental Eye Research, 2024
- JR14a: A novel antagonist of C3aR attenuates neuroinflammation in cerebral ischemia-reperfusion injuryBrain Research Bulletin, 2024
- Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activationGlia, 2022
- The complement C3‐C3aR pathway mediates microglia–astrocyte interaction following status epilepticusGlia, 2020
- Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritisExperimental Eye Research, 2018
- Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disordersBrain and Behavior, 2016
- The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer modelExperimental Neurology, 2015
- Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerveExperimental Eye Research, 2014
- Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgGActa Neuropathologica, 2013
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001